Caliper Life Sciences - Earnings better than the market estimates
11/3/2011 12:37:30 PM
Caliper Life Sciences Inc. (NASDAQ:CALP). Last Market Price: 10.48, Change: +0.01, % Change: (0.05%). Shares trade in the range of 10.48 - 10.50 dollars. It has a market capitalization of 556.30M dollars, making it a Small Cap Stock and has 53.06M outstanding shares. The company has a beta of 1.31, indicating, the stock to be more volatile than the market. As per the most recent quarterly report, the net income per share (EPS) is -0.17. It operates in Technology sector and belongs to Scientific and Technical Instr. industry. Percentage shares held by institutional investors is 71%. The company has a 52 week Price range (low - high) of $ 4.56 - 10.56. Average volumes of shares traded daily are 1,240,000. Volume traded in the last session was at 131,812, 0.11 times the average volume.
- Reports Q3 (Sep)
- EPS of $0.03 better than the market estimates
- Revenues rose 24.2% year on year to $36.9 million,
- Comprised of
- 16% organic growth,
- 6% acquisition-driven growth and
- 2% favorable currency benefit.
For Q2 (Jun '11), It had a Net profit margin of -8.45%, an Operating margin of -8.09%. Other Key stats and ratios are : Return on average assets of -9.18%, Return on average equity of -14.67%. The organization has an employee strength of 469
Consensus Recommendation is a Outperform.
Estimate for sales for the Year Ending Dec-11 show a mean of 149.38 million dollars, an estimate high of 149.70 million dollars and an estimate low of 149.00 million dollars. A year ago the figures stood at 126.65 million dollars.
Estimate for sales for the Year Ending Dec-12 show a mean of 162.79 million dollars, an estimate high of 164.56 million dollars and an estimate low of 160.00 million dollars. A year ago the figures stood at 136.80 million dollars.
Estimate for EPS for the Year Ending Dec-11 show a mean of 0.04 dollars, an estimate high of 0.05 dollars and an estimate low of 0.03 dollars. A year ago the figures stood at -0.01 dollars.
Estimate for EPS for the Year Ending Dec-12 show a mean of 0.11 dollars, an estimate high of 0.14 dollars and an estimate low of 0.06 dollars. A year ago the figures stood at 0.06 dollars.
Sales for Quarter Ending Jun-11 was estimated at 34.39 million dollars, however the actual sales figure stood at 38.34 million dollars, 3.95 million dollars more than estimates.
Sales for Quarter Ending Mar-11 was estimated at 33.46 million dollars, however the actual sales figure stood at 35.82 million dollars, 2.36 million dollars more than estimates.
|
|
